Thursday, January 24, 2013
The Helmsley Center for Genomic Medicine will enable scientists in a range of fields to explore how certain cellular pathways serve as lynchpins for chronic diseases, which could lead to new therapy targets.
The Salk Institute for Biological Studies has received a $42 million gift—the largest in the Institute’s history—to establish the Helmsley Center for Genomic Medicine (HCGM), a research center dedicated to decoding the common genetic factors underlying many complex chronic human diseases. The award, from The Leona M. and Harry B. Helmsley Charitable Trust, will support interdisciplinary research that paves the way to new therapies for chronic illnesses such as cancer, diabetes and Alzheimer’s disease...